4.8 Article

Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonist

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Drug development and the cellular quality control system

P. Michael Conn et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2009)

Article Pharmacology & Pharmacy

A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor

Chris J. van Koppen et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)

Article Endocrinology & Metabolism

Gonadotrophin resistance

Ilpo Huhtaniemi et al.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2006)

Article Endocrinology & Metabolism

Biological effect of a novel mutation in the third leucine-rich repeat of human luteinizing hormone receptor

Michael Yiu-Kwong Leung et al.

MOLECULAR ENDOCRINOLOGY (2006)

Article Endocrinology & Metabolism

Mutations in human gonadotropin and gonadotropin-receptor genes

IT Huhtaniemi et al.

ENDOCRINE (2005)

Review Cell Biology

Quality control in the endoplasmic reticulum

L Ellgaard et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)

Article Biochemistry & Molecular Biology

Ligands act as pharmacological chaperones and increase the efficiency of δ opioid receptor maturation

UE Petäjä-Repo et al.

EMBO JOURNAL (2002)

Review Physiology

Nephrogenic diabetes insipidus

JP Morello et al.

ANNUAL REVIEW OF PHYSIOLOGY (2001)

Article Medicine, Research & Experimental

Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants

JP Morello et al.

JOURNAL OF CLINICAL INVESTIGATION (2000)